At IHI, our core goals are to translate health research and innovation into tangible benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research.
IHI has a total budget of €2.4 billion and is funded jointly by the EU and by industry associations representing Europe’s life science industries.
IHI's governance structure reflects our status as a public-private partnership, while ensuring that we benefit from the input of the wider scientific and health community as well as the Member States and countries associated to Horizon Europe.
IHI is expected to have impacts on the research and innovation ecosystem; on patients and health systems; and on Europe’s competitiveness. Projects funded under the Innovative Medicines Initiative already demonstrate the impacts of the public-private partnership approach to research.